Form 4: Neogenomics General Counsel Alicia C. Olivo Reports Stock Sale
SEC Form 4
Alicia C. Olivo, General Counsel of Neogenomics, sold 1,049 shares of common stock at a price of $15.74 on May 15, 2024.
Summary
- On May 15, 2024, Alicia C. Olivo, the General Counsel of Neogenomics Inc., sold 1,049 shares of the company's common stock.
- The sale was executed at a price of $15.74 per share.
- Following the transaction, Ms. Olivo directly owns 44,867 shares of Neogenomics.
- Ms. Olivo also holds various stock options, performance stock units, and restricted stock units, which vest over different periods.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a stock sale by an insider, which is neither inherently positive nor negative.
Industry Context
This Form 4 filing is a routine disclosure of a transaction by a company insider and is a common occurrence in the market.
Stakeholder Impact
- The sale of shares by a company insider could be perceived negatively by some shareholders, although the impact is likely minimal given the relatively small number of shares sold.
Key Dates
| Date | Description |
|---|---|
| 09/30/2019 | Ms. Olivo was granted 1,394 stock options. |
| 05/01/2020 | Ms. Olivo was granted 1,024 stock options. |
| 05/01/2021 | Ms. Olivo was granted 516 stock options. |
| 08/01/2021 | Ms. Olivo was granted 1,117 stock options. |
| 05/01/2022 | Ms. Olivo was granted 22,222 stock options. |
| 09/01/2022 | Ms. Olivo was granted 55,332 stock options. |
| 05/11/2023 | Ms. Olivo was granted 36,508 stock options, 19,508 performance stock units, and 19,508 restricted stock units. |
| 02/23/2024 | Ms. Olivo was granted 42,344 stock options, 25,330 performance stock units, and 25,329 restricted stock units. |
| 05/15/2024 | Ms. Olivo sold 1,049 shares of common stock. |
| 05/16/2024 | Date of signature for the Form 4 filing. |
| 05/11/2026 | Vesting date for performance stock units granted on May 11, 2023. |
| 09/30/2026 | Expiration date for stock options granted on September 30, 2019. |
| 02/23/2027 | Vesting date for performance stock units granted on February 23, 2024. |
| 05/01/2027 | Expiration date for stock options granted on May 1, 2020. |
| 05/01/2028 | Expiration date for stock options granted on May 1, 2021. |
| 08/01/2028 | Expiration date for stock options granted on August 1, 2021. |
| 05/01/2029 | Expiration date for stock options granted on May 1, 2022. |
| 09/01/2029 | Expiration date for stock options granted on September 1, 2022. |
| 05/11/2030 | Expiration date for stock options granted on May 11, 2023. |
| 02/23/2034 | Expiration date for stock options granted on February 23, 2024. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.